Determination of amphetamines in human urine by liquid chromatography with fluorimetric detection using a solid-phase extraction procedure

Journal of Separation Science

Volumn 29, Issue 15, 2006, Pages 2322-2329

  Bugamelli, Francesca ^a   Mandrioli, Roberto ^a   Cavallini, Annalisa ^a   Baccini, Cesare ^b   Conti, Matteo ^b   Raggi, Maria Augusta ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Department of Hematology   (Italy)

Author keywords

Amphetamines; Fluorescence detection; HPLC; SPE procedure; Urine

Indexed keywords

DRUG PRODUCTS; EXTRACTION; FLUOROMETERS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; UREA;

AMPHETAMINES; FLUORESCENCE DETECTION; METHAMPHETAMINE; METHYLENEDIOXYMETHAMPHETAMINE; SOLID-PHASE EXTRACTION;

PHARMACOKINETICS;

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMITRIPTYLINE; AMOXAPINE; AMPHETAMINE; BROTIZOLAM; BUPRENORPHINE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; CODEINE; FLUOXETINE; FLURAZEPAM; FLUVOXAMINE; IMIPRAMINE; LORAZEPAM; MAPROTILINE; METHAMPHETAMINE; MIRTAZAPINE; MORPHINE; PAROXETINE; PHOSPHATE; PROTRIPTYLINE; REBOXETINE; SERTRALINE; TETRAHYDROCANNABINOLIC ACID; TRAZODONE; TRIETHYLAMINE; VENLAFAXINE;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG ISOLATION; DRUG STRUCTURE; FEASIBILITY STUDY; FLUOROMETRY; HUMAN; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; RELIABILITY; SOLID PHASE EXTRACTION; URINALYSIS;

AMPHETAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUOROMETRY; HUMANS; METHAMPHETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; REPRODUCIBILITY OF RESULTS; SOLID PHASE EXTRACTION; STREET DRUGS; SUBSTANCE ABUSE DETECTION;

EID: 33750466872     PISSN: 16159306     EISSN: 16159314     Source Type: Journal    
DOI: 10.1002/jssc.200600139     Document Type: Article

References (38)

1. Cole, J. C., Sumnall, H. R., Neurosci. Biobehav. Rev. 2003, 27, 199-217.
2. Hermle, L., Spitzer, M., Borchardt, D., Kovar, K A., Gouzoulis, E., Neuropsychopharmacology 1993, 8, 171-176.
3. Greer, G. R., Tolbert, R. J., Psychoactive Drugs 1996, 18, 319-327.
4. Hoffman, B. B., Lefkowitz, R. J., in: Gilman, A. G., Hardman, J. G., Limbird, L. E., Molinoff, P., Ruddon, R. W. (Eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th Edn., McGraw-Hill, New York 2001, pp. 199-248.
5. Battaglia, G., Brooks, B. P., Kulsakdinum, C., De Souza, E. B., Eur J. Pharmacol. 1988, 149, 159-163.
6. Inaba, D. S., Cohen, W. E., Uppers, Downers, All Arounders: Physical and Mental Effects of Psychoactive Drugs, CNS Productions, Medford (OR) 2003.
7. Young, L. Y., Koda-Kimble, M. A. (Eds.), Applied Therapeutics. The Clinical Use of Drugs, 6th Edn., Applied Therapeutics, Vancouver 1995, p. 84.
8. Kraemer, T., Maurer, H. H., J. Chromatogr. B 1998, 713, 163-187.
9. Kraemer, T., Wennig, R., Maurer, H. H., J. Anal. Toxicol. 2001, 25, 333-338.
10. Brandenberger, H., Maes, R. A. A. (Eds.), Analytical Toxicology for Clinical, Forensic and Pharmaceutical Chemists, De Gruyter, Berlin, NewYork 1997, p. 675.
11. Baccini, C., Droghe e Doping: Chimica, Biochimica, Farmacologia, Tossicologia, Epidemiologia e Metodi di Analisi, Piccin Nuova Libraria, Padua 2006.
12. Crane, T., Dawson, C. M., Tickner, T. R., Clin. Chem. 1993, 39, 549-349.
13. Davanzo, F., Morganti, C., Manfrè, S., Sesana, F., et al., Proceedings of the XIV Congresso Nazionale SITOX (Società Italiana di Tossicologia), Rome 2006, p. 261.
14. Soares, M. E., Carvalho, M., Carmo, H., Remiao, F., et al., Biomed. Chromatogr. 2004, 18, 125-131.
15. Li, N. Y., Li, Y., Sellers, E. M., Eur. J. Drug Metab. Pharmacokinet. 1997, 22, 427-432.
16. Law, M. Y. L., Moody, D. E., J. Liq. Chromatogr. 1995, 18, 2029-2043.
17. Talwar, D., Watson, I. D., Stewart, M. J., J. Chromatogr. B 1999, 735, 229-241.
18. Hutchaleelaha, A., Walters, A., Chow, H.-H., Mayersohn, M. J. Chromatogr. B 1994, 658, 103-112.
19. Wada, M., Nakamura, S., Tomita, M., Nakashima, M. N., Nakashima, K., Luminescence 2005, 20, 210-215.
20. Nakashima, K., Kaddoumi, A., Ishida, Y., Itoh, T., Taki, K., Biomed. Chromatogr. 2003, 17, 471-476.
21. Al-Dirbashi, O., Kuroda, N., Nakashima, K., Menichini, F., et al., Analyst 1998, 123, 2333-2337.
22. Al-Dirbashi, O., Kuroda, N., Akiyama, S., Nakashima, K., J. Chromatogr. B 1997, 695, 251-258.
23. Helmlin, H. J., Bracher, K., Bourquin, D., Vonlanthen, D., Brenneisen, R. J. Anal. Toxicol. 1996, 20, 432-440.
24. Picaro, N., Ortuno, J., Segua, J., Fare, M., et al., J. Pharm. Biomed. 1999, 21, 739-747.
25. Pellegrini, M., Rosati, F., Pacifici, R., Zuccaro, P., et al., J. Chromatogr. B 2002, 769, 243-251.
26. Tatsuno, M., Nishikawa, M., Katagi, M., Tsuchihashi, H., J. Anal. Toxicol. 1996, 20, 281-286.
27. Bogusz, M. J., Kala, M., Maier, R. D., J. Anal. Toxicol. 1997, 21, 59-69.
28. Boatto, G., Nieddu, M., Carta, A., Pau, A., et al., J. Chromatogr. B 2005, 814, 93-98.
29. Concheiro, M., de Castro, A., Quintela, O., Lopez-Rivadulla, M., Cruz, A., Forensic Sci. Int. 2005, 150, 221-226.
30. da Costa, J. L., da Matta Chasin, A. A., J. Chromatogr. B 2004, 811, 41-45.
31. Caslavska, J., Thormann, W., Electrophoresis 2004, 25, 1623-1631.
32. Shah, V. P., Midha, K. K., Findlay, J. W. A., Hill, H. M., et al., Pharm. Res. 2000, 17, 1551-1557.
33. United States Pharmacopeia, 28th Edn., United States Pharmacopeial Convention, Rockville, MD 2005, pp. 2748-2751.
34. Mehta, A. C., Schulman, S. G., J. Pharm. Sci. US 1974, 63, 1150-1151.
35. Antun, F., Smythies, J. R., Benington, F., Morin, R. D., et al., Experientia 1970, 27, 62-63.
36. La Croix, R., Pianezzola, E., Strolin Benedetti, M. J. Chromatogr. B 1994, 656, 251-258.
37. Nakashima, K, Kaddoumi, A., Yishida, Y., Itoh, T., Taki, K., Biomed. Chromatogr. 2003, 17, 471-476.
38. Namera, A., Yashiki, M., Yashiki, M., Nishida, K. T., Kojima, T., Jpn. J. Forensic Toxicol. 2003, 21, 227-234.